肾脏疾病

  • 网络Kidney disease;renal disease;CKD;ESRD
肾脏疾病肾脏疾病
  1. 终末期肾脏疾病透析患者主要病因为慢性肾小球肾炎(52.0%),其次为糖尿病肾病(16.0%),高血压肾病(13.2%),梗阻性肾病(9.0%);

    Main etiological factor of ESRD patients were chronic glomerulonephritis ( CGN )( 52.0 % ), followed by diabetic nephropathy ( 16.0 % ), hypertensive nephropathy ( 13.2 % ), and obstructive nephropathy ( 9.0 % ) .

  2. 胱蛋白酶抑制剂C在肾脏疾病诊断中的应用

    Application of cystatin C in diagnosing renal disease

  3. 尿C及尿酶测定在肾脏疾病中的应用

    The use of the determination of urine c_3 and urine enzyme in diseases of the kidney

  4. 肾脏疾病患者血脂及载脂蛋白AⅠB(100)CⅡ的测定及其临床意义探讨

    Clinical significance of determining the serum lipids and apolipoproteins a ⅰ B 100 C ⅱ in glomerular disorders

  5. 慢性肾脏疾病患者尿SOD排泄变化

    Urinary SOD Excretion in Patients with Chronic Renal Disease

  6. 在肾脏疾病中检测血清CystatinC的意义

    The meaning of detecting the serum cystatin C concentration in kidney diseases

  7. 对20例肾脏疾病患者分别进行肾脏动态MR检查及同位素检查,所得的MR肾图与同位素肾图进行对照。

    MR dynamic serial images and radionuclide renography were performed in 20 patients . MR renogram of each patient was correlated with radionuclide renography .

  8. 慢性肾脏疾病患者血清IL-2水平及其临床意义

    Serum Interleukin-2 Level in Patients with Chronic Kidney Disease and Its Clinical Significance

  9. CGRP和ET可能参与慢性肾脏疾病的发病。

    CGRP and ET might be contributive to the pathogenesis of chronic renal diseases .

  10. ICAM-1在原发性慢性肾脏疾病肾组织的表达及意义

    The Expression and Significance of ICAM-1 in Human Primary Chronic Kidney Disease

  11. 表现为ARF最常见的继发性肾脏疾病是血管炎、微血管病及管型肾病。

    The secondary renal diseases included vasculitis , microangiopathy and cast nephropathy .

  12. 慢性肾脏疾病中LDL-C两种测定方法的比较

    Comparison of two LDL-C Detecting Methods in Chronic Renal Diseases

  13. 小儿肾脏疾病的免疫状态和血、尿纤维蛋白降解产物(FDP)的观察

    Preliminary Observation on Immune Status of Children 's Kidney Diseases

  14. 肾脏疾病组与正常组BNP浓度差异显著(P<0.05);

    There were difference among nephrosis group with normal group ( P < 0.05 ) .

  15. 肾间质纤维化(renalinterstitialfibrosis,RIF)几乎是所有肾脏疾病进展到终末期肾功能衰竭的共同病理途径。

    Renal interstitial fibrosis ( RIF ) is the common pathologic pathway to end-stage renal failure in almost all renal disease .

  16. 心脏疾病、感染、肾脏疾病是引起SLE最常见的3个死亡原因。

    Heart disease , infections , and renal disease are the three most common causes of death of SLE patients .

  17. 目的探讨内皮素(ET)水平在慢性肾脏疾病发生、发展中所起的作用。

    Objective To study the significance of the changes of plasm , urinary endothelin ( ET ) in the occurrence , development of chronic kidney disease .

  18. CRF是各种原发性和继发性肾脏疾病持续性进展的共同转归,直接威胁患者的生命。文化冲突将影响到新生企业的生存和发展,新生企业只有主动进行文化变革才能消除冲突。

    To threaten straightly life of kidney patient . These conflicts will threaten the development of new corporation .

  19. 引起终末肾脏疾病的原发病包括高血压(29%),HIV(24%)和糖尿病(19%)。

    The primary etiologies for end stage renal disease ( ESRD ) were hypertension ( 29 % ), HIV ( 24 % ), and diabetes ( 19 % ) .

  20. 肾脏疾病患者血清中ANCA的荧光模式及其意义

    The significance of fluorescent patterns of antineutrophil cytoplasmic antibodies ( ANCA ) in renal diseases

  21. 方法用改良琼脂糖电泳法对正常体检者和162例肾脏疾病患者碱性磷酸酶(ALP)同工酶进行分离和定量分析。

    Methods ALP isoenzymes in the serum of normal healthy and 162 renal patients were separated quantitatively by improved agarose electrophoresis .

  22. 方法检测107例不同肾脏疾病患者的24h尿蛋白定量、晨尿尿蛋白/尿肌酐比值和尿蛋白/尿渗透压比值,并进行相关性分析。

    Methods Urine samples of 107 patients with renal diseases were analyzed for 24h urinary protein , protein-osmolality ratio and protein-creatinine ratio .

  23. 肾功能不全的疗效与合并糖尿病、动脉粥样硬化、治疗前血清肌酐(Scr)水平及其他肾脏疾病等显著相关。

    Predictors of favorable outcome for renal failure were nondiabetic status , atheromatous , serum creatinine before treatment and another coexistent renal disease .

  24. 原发性FSGS是一种正在增长的终末期肾脏疾病的病因。

    Primary FSGS is an increasing cause of end-stage renal disease .

  25. 目的:观察长程联合使用ACEI和ARB治疗慢性肾脏疾病的疗效和安全性。

    Objective : To investigate the effect of ACEI combining with ARB on chronic renal disease .

  26. ADMA在慢性肾脏疾病患者并发心血管疾病中的作用

    The Role Of ADMA in Cardiovascular Complication of Patients in Chronic Kidney Disease

  27. 目的:采用彩色多普勒超声检查,评估慢性肾脏疾病(ChronicKidneyDisease,CKD)5期透析前患者的甲状旁腺增生情况,并结合临床资料分析相关因素。

    Objective To evaluate the parathyroid status by colour Doppler ultrasonography in the patients with chronic kidney disease ( CKD ) stage 5 before dialysis , and to analyze the correlation factors .

  28. 结论:有较低体重指数尚未接受透析治疗的慢性肾脏疾病(CKD)患者有高的死亡率。

    Lower BMI is associated with greater mortality in patients with CKD not yet on dialysis therapy .

  29. 目的探讨REP高压快速蛋白电泳扫描积分对肾脏疾病的诊断和鉴别诊断价值。

    Objective To develop the diagnosis value of electrophoresis scanning integral calculus of serum proteins in various kidney diseases .

  30. 结论ET在小儿肾脏疾病发病机理及病情进展中可能起重要作用,其值高低与病情严重程度及预后有关。

    Conclusion The ET possibly plays an important role in pathogenesis of these renal disease and its level change may be related to the progress and prognosis of these renal disease .